Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

170 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Natalizumab for active Crohn's disease.
Ghosh S, Goldin E, Gordon FH, Malchow HA, Rask-Madsen J, Rutgeerts P, Vyhnálek P, Zádorová Z, Palmer T, Donoghue S; Natalizumab Pan-European Study Group. Ghosh S, et al. Among authors: malchow ha. N Engl J Med. 2003 Jan 2;348(1):24-32. doi: 10.1056/NEJMoa020732. N Engl J Med. 2003. PMID: 12510039 Clinical Trial.
Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial.
Gassull MA, Fernández-Bañares F, Cabré E, Papo M, Giaffer MH, Sánchez-Lombraña JL, Richart C, Malchow H, González-Huix F, Esteve M; Eurpoean Group on Enteral Nutrition in Crohn's Disease. Gassull MA, et al. Among authors: malchow h. Gut. 2002 Aug;51(2):164-8. doi: 10.1136/gut.51.2.164. Gut. 2002. PMID: 12117873 Free PMC article. Clinical Trial.
A comparison of budesonide with prednisolone for active Crohn's disease.
Rutgeerts P, Löfberg R, Malchow H, Lamers C, Olaison G, Jewell D, Danielsson A, Goebell H, Thomsen OO, Lorenz-Meyer H, et al. Rutgeerts P, et al. Among authors: malchow h. N Engl J Med. 1994 Sep 29;331(13):842-5. doi: 10.1056/NEJM199409293311304. N Engl J Med. 1994. PMID: 8078530 Clinical Trial.
170 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page